ALB and diabetes mellitus: These vitro glycation models appeared relevant to what could be encountered in vivo as most of oxidative damages, identified in our in vitro glycated albumin and erythrocytes preparations, were retrieved in albumin and erythrocytes isolated from diabetics [10,15,69].